Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions.

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• Apoptosis signal-regulating kinase 1 (ASK1) is a MAP3K family member regulating cellular stress responses.
• ASK1 activation of JNKs and p38 MAPKs contributes to cell death, inflammation, and fibrosis.
• Dysregulated ASK1 signaling is implicated in neurological, cardiovascular, and metabolic diseases, as well as cancer.

Purpose of the Study:

• To review recent structural findings on ASK1 regulation.
• To summarize ASK1's role in various pathological conditions.
• To highlight the therapeutic potential of ASK1 inhibition.

Main Methods:

• Literature review of structural biology studies on ASK1.
• Analysis of ASK1's involvement in disease pathogenesis.
• Evaluation of therapeutic strategies targeting ASK1.

Main Results:

• ASK1 acts as a central mediator of oxidative and ER stress responses.
• Sustained activation of downstream kinases (JNKs, p38 MAPKs) by ASK1 drives disease progression.
• Existing inhibitors for JNK and p38 kinases have limitations in efficacy and side effects.

Conclusions:

• Targeted inhibition of ASK1 presents a promising therapeutic avenue.
• Understanding ASK1 structure and regulation is crucial for developing effective inhibitors.
• ASK1 inhibition may offer a novel treatment strategy for a range of severe diseases.